These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 22784018)

  • 21. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memantine in neurological disorders - schizophrenia and depression.
    Czarnecka K; Chuchmacz J; Wójtowicz P; Szymański P
    J Mol Med (Berl); 2021 Mar; 99(3):327-334. PubMed ID: 33447926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memantine: pharmacological properties and clinical uses.
    Kumar S
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
    Owen RT
    Drugs Today (Barc); 2012 Jul; 48(7):469-78. PubMed ID: 22844658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memantine in the treatment of mild-to-moderate Alzheimer's disease.
    Cosman KM; Boyle LL; Porsteinsson AP
    Expert Opin Pharmacother; 2007 Feb; 8(2):203-14. PubMed ID: 17257090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder.
    Teng CT; Demetrio FN
    Braz J Psychiatry; 2006 Sep; 28(3):252-4. PubMed ID: 17063225
    [No Abstract]   [Full Text] [Related]  

  • 29. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.
    Parsons CG; Danysz W; Quack G
    Neuropharmacology; 1999 Jun; 38(6):735-67. PubMed ID: 10465680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease.
    Emre M; Mecocci P; Stender K
    J Alzheimers Dis; 2008 Jun; 14(2):193-9. PubMed ID: 18560130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.
    Bakchine S; Loft H
    J Alzheimers Dis; 2007 Jul; 11(4):471-9. PubMed ID: 17656827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NMDA receptor antagonists memantine and ketamine as anti-migraine agents.
    Podkowa K; Czarnacki K; Borończyk A; Borończyk M; Paprocka J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1371-1398. PubMed ID: 36869904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Memantine: a review of possible uses in child and adolescent psychiatry.
    Hosenbocus S; Chahal R
    J Can Acad Child Adolesc Psychiatry; 2013 May; 22(2):166-71. PubMed ID: 23667364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine for dementia.
    Areosa Sastre A; McShane R; Sherriff F
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003154. PubMed ID: 15495043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
    Aman MG; Findling RL; Hardan AY; Hendren RL; Melmed RD; Kehinde-Nelson O; Hsu HA; Trugman JM; Palmer RH; Graham SM; Gage AT; Perhach JL; Katz E
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):403-412. PubMed ID: 26978327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memantine reduces mania-like symptoms in animal models.
    Gao Y; Payne RS; Schurr A; Hougland T; Lord J; Herman L; Lei Z; Banerjee P; El-Mallakh RS
    Psychiatry Res; 2011 Aug; 188(3):366-71. PubMed ID: 21269711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL; Mackell J; Kaufer D
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
    Kulkarni J; Thomas N; Hudaib AR; Gavrilidis E; Grigg J; Tan R; Cheng J; Arnold A; Gurvich C
    CNS Drugs; 2018 Feb; 32(2):179-187. PubMed ID: 29549516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.
    Peskind ER; Potkin SG; Pomara N; Ott BR; Graham SM; Olin JT; McDonald S
    Am J Geriatr Psychiatry; 2006 Aug; 14(8):704-15. PubMed ID: 16861375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.